Jennewein Biotechnologie GmbH

Contact

About Jennewein Biotechnologie

Founded in 2005, Jennewein Biotechnologie GmbH is the world-leader in the manufacturing of human milk-oligosaccharides (HMO´s). These saccharides are an important component of human breast milk. The company has developed a unique manufacturing process, which is based on cientific research and results which in turn ensures a high quality product. Jennewein´s human milk oligosaccharides are produced using the latest in fermentation technology. Human milk oligosaccharides produced by Jennewein Biotechnologie

Read more about Jennewein Biotechnologie

Facts about Jennewein Biotechnologie Facts about Jennewein Biotechnologie

Focus : Manufacturer
Industry : biotechnology

Product portfolio of Jennewein Biotechnologie

Product portfolio

Show all

News about Jennewein Biotechnologie

24-Sep-2020 | business & finance

Chr. Hansen acquires Jennewein Biotechnologie to enter and lead the high-growth Human Milk Oligosaccharides market

The acquisition is fully in line with Chr. Hansen’s 2025 Strategy

Read news

09-Jan-2020 | business & finance

A milestone for Jennewein Biotechnologie for the GRAS approval of the HMO-mix

Jennewein Biotechnology announces another milestone in the Worldwide approval of a new product generation, the "HMO-Mix". The data of the toxicological ...

Read news

25-Nov-2019 | business & finance

Interim status of the clinical study "Growth and Tolerance" by Jennewein Biotechnologie

Jennewein Biotechnologie GmbH, the leading manufacturer of human milk oligosaccharides, initiated its first clinical study in July 2018. The so-called " ...

Read news

07-Feb-2019 | science

Cooperation in the field of human milk oligosaccharide research

Jennewein Biotechnologie GmbH, the global leader in the research and manufacture of human milk oligosaccharides (HMO),and Inner Mongolia Yili Industrial ...

Read news

10-Oct-2018 | business & finance